A histone deacetylase inhibitor (HDACi) MGCD0103 has been shown to inhibit autophagy by functionalizing PI3K/AKT/mTOR pathway as well as caspases in B-cell chronic lymphocytic leukemia cells (CLL) [38]. This evidence concerns the gene MTOR and B-cell chronic lymphocytic leukemia.